Injectables
All figures are observed UK market ranges as at mid-2026, gathered across London, the South East, the Midlands, the North West and Scotland. They are indicative, not quotations.
| Treatment | Typical range | Notes |
|---|---|---|
| Botulinum toxin, one area | £150, £280 | Frown, forehead or crow's feet |
| Botulinum toxin, three areas | £250, £450 | Bundled pricing is standard |
| Masseter treatment | £280, £500 | Higher dose requirement |
| Hyperhidrosis, underarms | £400, £750 | Substantially higher dosing |
| Dermal filler, per ml | £250, £600 | Wide variation by product and area |
| Lip filler, 0.5–1ml | £220, £450 | |
| Tear trough | £400, £800 | Technically demanding, price reflects risk |
| Skin booster course | £500, £1,000 | Usually two to three sessions |
Skin treatments
| Treatment | Typical range |
|---|---|
| Device facial, e.g. HydraFacial | £110, £340 |
| Superficial chemical peel | £90, £200 |
| Medium-depth peel | £250, £600 |
| Microneedling, per session | £180, £400 |
| Radiofrequency microneedling | £450, £1,200 |
| Fractional laser resurfacing | £600, £2,000 |
| IPL, per session | £150, £350 |
Device treatments show the widest spread of any category, because the same trade name can describe very different energy settings and protocols. Our guide to choosing between device facials covers how to tell them apart.
Body and contouring
| Treatment | Typical range |
|---|---|
| Cryolipolysis, per area | £400, £900 |
| Injectable fat dissolving, per area | £200, £500 |
| EMS muscle stimulation course | £1,000, £2,500 |
| Endolift, submental | £1,200, £2,000 |
| Surgical liposuction, one area | £3,000, £6,000 |
Regenerative
| Treatment | Typical range |
|---|---|
| Polynucleotides, per session | £250, £450 |
| PRP, facial, per session | £300, £600 |
| PRP, hair, course of three | £900, £1,800 |
| Exosome treatment, per session | £400, £900 |
| Collagen stimulator, per vial | £450, £900 |
Regenerative pricing is the least standardised in the sector, partly because the products themselves vary enormously in concentration and preparation, and partly because the category is new enough that no pricing convention has settled. Our assessment of what the polynucleotide evidence actually supports is relevant before committing to a course.
Why the ranges are so wide
Four factors explain most of the variation, and only one of them relates to clinical quality.
- Location. Central London commands a premium of roughly 40 to 70 per cent over regional pricing for identical treatments.
- Product cost. Genuine branded products carry real cost. Unusually low pricing sometimes indicates parallel-imported or non-genuine product.
- Time allocated. A thirty-minute appointment and a ninety-minute appointment can carry the same treatment name.
- Positioning. A significant share of price difference is brand positioning rather than anything the patient receives.
The uncomfortable conclusion for patients is that price is a weak signal of quality in both directions. Expensive does not mean safe, and cheap does not always mean poor. Verification through Save Face or the relevant professional register tells you considerably more than the price list does. Our explainer on what is and is not regulated covers how to do that check.
Pricing patterns to be cautious about
- Time-limited discounts on injectables. Pressure selling and medical decision-making do not belong together.
- Large course pre-payment at first consultation. Before anyone has seen how you respond to one session.
- Prices far below market. The economics have to give somewhere, usually in product, time or qualification.
- Per-area pricing with undefined areas. Ask exactly what an "area" means before agreeing.
- Loyalty schemes on prescription medicines. Widely regarded as inappropriate by professional bodies.
